TZD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TZD, covering 2021-05-04 to 2021-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen [Phase 4]